Musculoskeletal Diseases Treatment Market and COVID-19 | Impact Research By General Electric, Koninklijke Philips N.V., Siemens AG, Canon Medical Systems Corporation, Hitachi,Accuray Incorporated, MR Solutions, Alltech Medical Systems and Others

The Insight Partners analysts forecasts the latest report on “Musculoskeletal Diseases Treatment Market (Covid-19) Impact and Analysis by 2025”, according to report; The Musculoskeletal Diseases Treatment Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Musculoskeletal Diseases Treatment Market.

The study provides details such as the market share, Market Insights, Strategic Insights, Segmentation and key players in the Musculoskeletal Diseases Treatment Market.

Download Sample Report of Musculoskeletal Diseases Treatment Market Report @ https://www.theinsightpartners.com/sample/TIPMD00002090/?openpr-10225

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

The global musculoskeletal diseases treatment market is expected to reach US$ 5,730.8 Mn in 2025 from US$ 3,837.9 in 2017. The musculoskeletal diseases treatment market is estimated to grow with a CAGR of 5.3% from 2018-2025.

Some of the Major Market Players Are:

General Electric
Siemens AG
CANON MEDICAL SYSTEMS CORPORATION
Koninklijke Philips N.V.
Hitachi, Ltd.
Accuray Incorporated
MR Solutions
Alltech Medical Systems
Terason Division Teratech Corporation
Echo-Son SA

Market Insights

Rising Prevalence of Musculoskeletal Disorders
Musculoskeletal disorders are associated with sports, occupational injuries and age-related dysfunction. Some of the most common musculoskeletal diseases are back pain, rheumatoid arthritis, osteoarthritis, osteoporosis, septic arthritis, gout, myasthenia gravis, systemic lupus erythematous (SLE), and others. Musculoskeletal system is the diagnosis and management of all acute and chronic conditions affecting musculoskeletal system, i.e., muscles, bones, tendons, joints and ligaments and treatment of non-surgical lesions of the musculoskeletal system. The rising prevalence of musculoskeletal diseases are the major factors of the market growth. For instance, according to Arthritis Foundation, in 2017, approximately 54 million adults have been diagnosed with arthritis. Almost 300,000 babies and children have arthritis or a rheumatic condition. The common type of arthritis is osteoarthritis, which affects approximately 31 million Americans. By the end of 2040, number of people expected to have doctor-diagnosed arthritis will be above 78 million. As per the report published in 2018 of Healthline Media, rheumatoid arthritis (RA) affects 41 in every 100,000 people per year. Approximately, 1.3 million Americans have RA. Women are about two to three times more likely to get RA than men. The lifetime risk of developing RA is 3.6% for women and 1.7% for men. However, RA can strike at any age even small children can get it. Smoking is the mostly associated risk factor when it comes to the onset of RA in patients. A history of smoking is said to increase the risk of developing RA by as much 2.4%.

Technological Advancements in Musculoskeletal Disease Diagnosis

Musculoskeletal diseases treatment is performed with the help of most flexible diagnostic imaging modalities that has capabilities to characterize a wide range of parameters in the living subject as well as provide an exquisite spatial resolution. This technique has been explored by the numerous market players to achieve remarkable precision through extensive innovation in the product design and features. Various recent technological developments are marked in the evolution of musculoskeletal diseases treatment techniques over the past few years.

For instance, in June 2018, Konica Minolta Healthcare Americas, Inc., launched the SONIMAGE MX1 portable ultrasound system, developed for musculoskeletal (MSK) and orthopedic practices, interventional guidance and outpatient centers. SONIMAGE MX1 is made with power, portability that physicians need to make a confident and efficient diagnosis at the point-of-care. In March 2018, Philips introduced a new 3-tesla MRI scanner named Ingenia Elition 3.0T at the ECR 2018 in Vienna. Thus, the innovative steps and technological advancements undertaken by new entrants as well as established market players to improve the quality and efficacy of musculoskeletal diseases treatment scans is expected to favor the growth of the market in the years to come.

Strategic Insights

Product launch/update and agreements & partnerships were observed as the most adopted strategy in global musculoskeletal disease treatment industry. Few of the product approvals and partnerships made by the players in the market are listed below;

2018: In Spetember, Royal Philips launched the Ingenia Ambition X 1.5T MR. The product is the latest advance in the Ingenia MRI portfolio, that comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis.

2017: In November, Canon Medical Systems announced the launch of the new package for its iSeries scanners. The series will include Aplio i700, i800, and i900 which will be assessing the patients suffering from diseases.

2018: In January, AllTech Medical Systems America and RSTI signed an agreement to provide training. The agreement focusses RSTI offering an MRI service training program at Alltech Medical Systems America’s headquarters in Solon, Ohio. The program is to provide complete spectrum of service solutions and MRI training courses.

MARKET SEGMENTATION

By Disease

• Arthritis
• Osteoarthritis
• Osteoporosis
• Spondylitis
• Others

By Imaging Modality

• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• Ultrasound
• Others

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global Musculoskeletal Diseases Treatment Market based on various segments. It also provides market size and forecast estimates from the year 2018 to 2025 with respect to five major regions. The Musculoskeletal Diseases Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

Promising Regions & Countries Mentioned in The Musculoskeletal Diseases Treatment Market Report:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East & Africa

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Major Features of Musculoskeletal Diseases Treatment Market Report:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Musculoskeletal Diseases Treatment market
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global Musculoskeletal Diseases Treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.

Purchase a copy of Musculoskeletal Diseases Treatment Market research report @ https://www.theinsightpartners.com/buy/TIPMD00002090/?openpr-10225

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.